JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) - Net Assets

Latest as of September 2025: Rs38.06 Billion INR ≈ $411.58 Million USD

Based on the latest financial reports, JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) has net assets worth Rs38.06 Billion INR (≈ $411.58 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs47.12 Billion ≈ $509.63 Million USD) and total liabilities (Rs9.07 Billion ≈ $98.05 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check JB Chemicals & Pharmaceuticals Limited asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs38.06 Billion
% of Total Assets	80.76%
Annual Growth Rate	13.27%
5-Year Change	89.33%
10-Year Change	213.45%
Growth Volatility	11.14

JB Chemicals & Pharmaceuticals Limited - Net Assets Trend (2005–2025)

This chart illustrates how JB Chemicals & Pharmaceuticals Limited's net assets have evolved over time, based on quarterly financial data. Also explore JBCHEPHARM asset base for the complete picture of this company's asset base.

Annual Net Assets for JB Chemicals & Pharmaceuticals Limited (2005–2025)

The table below shows the annual net assets of JB Chemicals & Pharmaceuticals Limited from 2005 to 2025. For live valuation and market cap data, see JB Chemicals & Pharmaceuticals Limited stock valuation.

Year	Net Assets	Change
2025-03-31	Rs34.33 Billion ≈ $371.30 Million	+17.45%
2024-03-31	Rs29.23 Billion ≈ $316.15 Million	+17.86%
2023-03-31	Rs24.80 Billion ≈ $268.24 Million	+15.98%
2022-03-31	Rs21.39 Billion ≈ $231.28 Million	+17.93%
2021-03-31	Rs18.13 Billion ≈ $196.12 Million	+26.11%
2020-03-31	Rs14.38 Billion ≈ $155.51 Million	-3.03%
2019-03-31	Rs14.83 Billion ≈ $160.37 Million	+2.67%
2018-03-31	Rs14.44 Billion ≈ $156.20 Million	+5.75%
2017-03-31	Rs13.66 Billion ≈ $147.71 Million	+24.70%
2016-03-31	Rs10.95 Billion ≈ $118.46 Million	+10.10%
2015-03-31	Rs9.95 Billion ≈ $107.59 Million	-4.60%
2014-03-31	Rs10.43 Billion ≈ $112.78 Million	+2.21%
2013-03-31	Rs10.20 Billion ≈ $110.34 Million	+5.19%
2012-03-31	Rs9.70 Billion ≈ $104.90 Million	+40.26%
2011-03-31	Rs6.92 Billion ≈ $74.79 Million	+21.73%
2010-03-31	Rs5.68 Billion ≈ $61.44 Million	+21.16%
2009-03-31	Rs4.69 Billion ≈ $50.71 Million	+3.50%
2008-03-31	Rs4.53 Billion ≈ $48.99 Million	+8.26%
2007-03-31	Rs4.18 Billion ≈ $45.26 Million	+26.66%
2006-03-31	Rs3.30 Billion ≈ $35.73 Million	+16.26%
2005-03-31	Rs2.84 Billion ≈ $30.73 Million	--

Equity Component Analysis

This analysis shows how different components contribute to JB Chemicals & Pharmaceuticals Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 2930689700000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2025)

Component	Amount	Percentage
Retained Earnings	Rs29.31 Billion	85.36%
Common Stock	Rs155.70 Million	0.45%
Other Comprehensive Income	Rs3.23 Billion	9.40%
Other Components	Rs1.64 Billion	4.79%
Total Equity	Rs34.33 Billion	100.00%

JB Chemicals & Pharmaceuticals Limited Competitors by Market Cap

The table below lists competitors of JB Chemicals & Pharmaceuticals Limited ranked by their market capitalization.

Company	Market Cap
Jiangsu Changshu Rural Commercial Bank Co Ltd SHG:601128	$3.55 Billion
Chunghwa Precision Test Tech Co Ltd TWO:6510	$3.55 Billion
IGO LTD SP.ADR/2 F:IDZ1	$3.55 Billion
NCsoft Corp KO:036570	$3.56 Billion
iRay Technology Co Ltd SHG:688301	$3.55 Billion
Endurance Technologies Limited NSE:ENDURANCE	$3.55 Billion
Gibson Energy Inc. TO:GEI	$3.54 Billion
Centrus Energy Corp. NYSE MKT:LEU	$3.54 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in JB Chemicals & Pharmaceuticals Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 29,233,300,000 to 34,333,200,000, a change of 5,099,900,000 (17.4%).
Net income of 6,595,800,000 contributed positively to equity growth.
Dividend payments of 2,370,400,000 reduced retained earnings.
Share repurchases of 240,027,000 reduced equity.
New share issuances of 240,000,000 increased equity.
Other comprehensive income increased equity by 1,958,680,000.
Other factors decreased equity by 1,084,153,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Rs6.60 Billion	+19.21%
Dividends Paid	Rs2.37 Billion	-6.9%
Share Repurchases	Rs240.03 Million	-0.7%
Share Issuances	Rs240.00 Million	+0.7%
Other Comprehensive Income	Rs1.96 Billion	+5.7%
Other Changes	Rs-1.08 Billion	-3.16%
Total Change	Rs-	17.45%

Book Value vs Market Value Analysis

This analysis compares JB Chemicals & Pharmaceuticals Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 9.45x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 57.92x to 9.45x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2005-03-31	Rs35.28	Rs2043.40	x
2006-03-31	Rs41.02	Rs2043.40	x
2007-03-31	Rs49.69	Rs2043.40	x
2008-03-31	Rs53.72	Rs2043.40	x
2009-03-31	Rs55.60	Rs2043.40	x
2010-03-31	Rs67.37	Rs2043.40	x
2011-03-31	Rs81.69	Rs2043.40	x
2012-03-31	Rs114.62	Rs2043.40	x
2013-03-31	Rs120.44	Rs2043.40	x
2014-03-31	Rs123.04	Rs2043.40	x
2015-03-31	Rs117.31	Rs2043.40	x
2016-03-31	Rs128.95	Rs2043.40	x
2017-03-31	Rs160.77	Rs2043.40	x
2018-03-31	Rs171.68	Rs2043.40	x
2019-03-31	Rs180.08	Rs2043.40	x
2020-03-31	Rs182.24	Rs2043.40	x
2021-03-31	Rs234.16	Rs2043.40	x
2022-03-31	Rs275.62	Rs2043.40	x
2023-03-31	Rs158.37	Rs2043.40	x
2024-03-31	Rs184.34	Rs2043.40	x
2025-03-31	Rs216.33	Rs2043.40	x

Capital Efficiency Dashboard

This dashboard shows how efficiently JB Chemicals & Pharmaceuticals Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 19.21%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 16.83%
• Asset Turnover: 0.92x
• Equity Multiplier: 1.24x
Recent ROE (19.21%) is above the historical average (17.82%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2005	20.53%	16.26%	0.87x	1.45x	Rs299.28 Million
2006	21.26%	15.08%	0.92x	1.53x	Rs371.99 Million
2007	14.86%	11.83%	0.74x	1.70x	Rs203.31 Million
2008	10.00%	8.06%	0.76x	1.64x	Rs179.40K
2009	5.48%	3.59%	0.96x	1.59x	Rs-211.79 Million
2010	20.90%	16.03%	0.89x	1.47x	Rs619.41 Million
2011	20.15%	16.55%	0.84x	1.45x	Rs701.69 Million
2012	69.89%	84.54%	0.67x	1.23x	Rs5.81 Billion
2013	7.79%	10.11%	0.60x	1.27x	Rs-225.83 Million
2014	5.90%	6.55%	0.69x	1.30x	Rs-427.85 Million
2015	10.09%	9.57%	0.71x	1.49x	Rs9.18 Million
2016	14.80%	13.86%	0.75x	1.42x	Rs525.07 Million
2017	13.50%	14.05%	0.78x	1.23x	Rs476.96 Million
2018	9.60%	9.99%	0.78x	1.22x	Rs-58.15 Million
2019	13.07%	12.01%	0.90x	1.21x	Rs454.54 Million
2020	18.95%	15.61%	0.96x	1.26x	Rs1.28 Billion
2021	24.75%	22.33%	0.90x	1.24x	Rs2.67 Billion
2022	18.06%	15.90%	0.93x	1.22x	Rs1.72 Billion
2023	16.52%	13.15%	0.88x	1.43x	Rs1.62 Billion
2024	18.90%	15.86%	0.87x	1.37x	Rs2.60 Billion
2025	19.21%	16.83%	0.92x	1.24x	Rs3.16 Billion

Industry Comparison

This section compares JB Chemicals & Pharmaceuticals Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $23,713,303,062
Average return on equity (ROE) among peers: 8.81%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM)	Rs38.06 Billion	20.53%	0.24x	$3.55 Billion
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)	$988.60 Million	6.59%	1.36x	$27.93 Million
Aarti Drugs Limited (AARTIDRUGS)	$6.52 Billion	21.67%	1.42x	$371.43 Million
Aarti Pharmalabs Limited (AARTIPHARM)	$19.90 Billion	13.69%	0.46x	$725.68 Million
Abbott India Limited (ABBOTINDIA)	$36.99 Billion	32.48%	0.40x	$5.85 Billion
Ajanta Pharma Limited (AJANTPHARM)	$1.16 Billion	12.69%	1.32x	$3.81 Billion
Akums Drugs and Pharmaceutical (AKUMS)	$6.25 Billion	-40.39%	3.91x	$906.19 Million
Alkem Laboratories Limited (ALKEM)	$88.47 Billion	18.60%	0.59x	$6.98 Billion
Amrutanjan Health Care Limited (AMRUTANJAN)	$1.46 Billion	16.82%	0.29x	$178.52 Million
Alembic Pharmaceuticals Limited (APLLTD)	$51.90 Billion	11.24%	0.50x	$1.60 Billion
Aurobindo Pharma Limited (AUROPHARMA)	$23.50 Billion	-5.26%	1.65x	$8.73 Billion

About JB Chemicals & Pharmaceuticals Limited

NSE:JBCHEPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$3.55 Billion

Rs328.02 Billion INR

Market Cap Rank

#4460 Global

#189 in India

Share Price

Rs2043.40

Change (1 day)

-0.86%

52-Week Range

Rs1504.40 - Rs2138.60

All Time High

Rs2138.60